Lincoln Pharmaceuticals Limited (LINCOLN)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
296.9
4.5(1.54%)

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Pricing Updates

TODAY'S HIGH

299

TODAY'S LOW

291.15

52 WEEK HIGH

414.7

52 WEEK LOW

255

Major Holders

% of Shares Held by
All Insider

66.65%

% of Shares Held by
Institutions

0.03%

% of Float Held by
Institutions

0.10%

Number of Institutions
Holding Shares

1

Company Overview

MARKET CAP

594.68 Cr.

ETERPRISE VALUE

472.51 Cr.

NO. OF SHARES

2 Cr.

BOOK VALUE

215.966

DIV. YIELD

1.5%

DEBT

2.04 Cr.

GROSS PROFIT

253.54 Cr.

CASH

115.60 Cr.

REVENUE

472.12 Cr.

REVENUE/SHARE

235.738

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-12.52 Cr.-43.99 Cr.-14.35 Cr.-6.16 Cr.
Change To Liabilities14.59 Cr.5.54 Cr.7.22 Cr.-14.04 Lakhs
Total cashflows from Investing Activities-78.08 Cr.-64.22 Cr.-30.88 Cr.-18.18 Cr.
Net Borrowings1.48 Cr.-4.55 Cr.-28.53 Cr.-27.67 Cr.
Total Cash from Financing Activities-2.55 Cr.-5.74 Cr.-37.75 Cr.-35.76 Cr.
Other Liabilities17.06 Cr.3.95 Cr.-74.29 Lakhs3.54 Cr.
Total Assets0000
Net Income69.35 Cr.62.22 Cr.51.43 Cr.48.71 Cr.
Change in Cash-4.50 Cr.-70.29 Lakhs6.77 Cr.-1.11 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities76.13 Cr.69.26 Cr.75.41 Cr.52.84 Cr.
Depreciation8.08 Cr.7.42 Cr.7.19 Cr.6.60 Cr.
Other Cashflows from Investing Activities-8.12 Cr.1.61 Cr.1.27 Cr.6.51 Cr.
Dividends Paid-3 Cr.-3 Cr.-6 Cr.-3 Cr.
Change to Inventory-26.12 Cr.78.35 Lakhs-11.17 Cr.9.18 Cr.
Change to Account Receivables-3.11 Cr.-10.08 Cr.19.01 Cr.-13.70 Cr.
Other Cashflows from Financing Activities-1.03 Cr.-1.19 Cr.-3.22 Cr.-5.09 Cr.
Change to Net Income-3.71 Cr.-71.84 Lakhs2.31 Cr.-1.44 Cr.
Capital Expenditures-45.52 Cr.-8.75 Cr.-7.69 Cr.-14.93 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax95.93 Cr.83.72 Cr.67.23 Cr.62.19 Cr.
Minority Interest040.76 Lakhs38.20 Lakhs35.52 Lakhs
Net Income87.39 Cr.79.80 Cr.58.33 Cr.60.82 Cr.
Selling General Administrative70.46 Cr.75.66 Cr.73.49 Cr.66 Cr.
Gross Profit253.54 Cr.223.28 Cr.200.35 Cr.186.31 Cr.
Ebit87.39 Cr.79.80 Cr.58.33 Cr.60.82 Cr.
Operating Income87.39 Cr.79.80 Cr.58.33 Cr.60.82 Cr.
Other Operating Expenses87.59 Cr.60.25 Cr.59.11 Cr.52.13 Cr.
Interest Expense-1.45 Cr.-1.20 Cr.-1.49 Cr.-3.09 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense26.58 Cr.21.47 Cr.15.76 Cr.13.45 Cr.
Total Revenue472.12 Cr.424.18 Cr.386.49 Cr.366.14 Cr.
Total Operating Expenses384.73 Cr.344.38 Cr.328.15 Cr.305.32 Cr.
Cost of Revenue218.58 Cr.200.90 Cr.186.13 Cr.179.82 Cr.
Total Other Income Expense Net8.54 Cr.3.91 Cr.8.89 Cr.1.37 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.69.35 Cr.62.24 Cr.51.46 Cr.48.73 Cr.
Net Income Applicable to Common Shares69.35 Cr.62.22 Cr.51.43 Cr.48.71 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets38.27 Lakhs39.81 Lakhs36.94 Lakhs42.41 Lakhs
Capital Surplus064.61 Cr.64.61 Cr.64.61 Cr.
Total Liabilities101.47 Cr.83.67 Cr.75.91 Cr.96.28 Cr.
Stock Holder Equity432.87 Cr.375.29 Cr.313.08 Cr.269.34 Cr.
Minority Interest040.76 Lakhs38.20 Lakhs35.52 Lakhs
Other Liabilities16.78 Cr.10.52 Cr.6.92 Cr.4.32 Cr.
Total Assets534.35 Cr.459.37 Cr.389.38 Cr.365.98 Cr.
Common Stock20.02 Cr.20 Cr.20 Cr.20 Cr.
Retained Earnings0290.63 Cr.228.45 Cr.184.24 Cr.
Other Liabilities10.99 Cr.9.98 Cr.9.48 Cr.9.25 Cr.
Good Will09.22 Cr.9.22 Cr.9.22 Cr.
Treasury Stock412.84 Cr.4.11 Lakhs2.15 Lakhs48.30 Lakhs
Other Assets33.57 Cr.31.28 Cr.18.54 Cr.18.85 Cr.
Cash18.79 Cr.11.43 Cr.12.23 Cr.5.45 Cr.
Current Liabilities90.48 Cr.73.54 Cr.65.58 Cr.85.33 Cr.
Long Term Asset Charges0000
Short Long Term Debt2.04 Cr.37.52 Lakhs39.19 Lakhs1.82 Cr.
Other Stockholder Equity412.84 Cr.4.11 Lakhs2.15 Lakhs48.30 Lakhs
Property Plant Equipment147.55 Cr.111.92 Cr.113.16 Cr.113.35 Cr.
Total Cur. Assets352.84 Cr.306.45 Cr.247.99 Cr.224.04 Cr.
Long Term Investments26 k8.55 Lakhs8.55 Lakhs8.55 Lakhs
Net Tangible Assets432.49 Cr.365.66 Cr.303.49 Cr.259.69 Cr.
Short Term Investments96.80 Cr.69 k2.44 Lakhs3.02 Lakhs
Net Receivables147.71 Cr.130.79 Cr.117.75 Cr.127.34 Cr.
Long Term Debt014.45 Lakhs84.89 Lakhs1.69 Cr.
Inventory72.74 Cr.46.61 Cr.47.39 Cr.36.22 Cr.
Accounts Payable71.65 Cr.56.79 Cr.51.24 Cr.44.01 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account